Vis enkel innførsel

dc.contributor.authorHalle, Mari Kyllesøen_US
dc.date.accessioned2017-12-05T14:48:47Z
dc.date.available2017-12-05T14:48:47Z
dc.date.issued2017-11-10
dc.identifier.isbn978-82-308-3918-8en_US
dc.identifier.urihttps://hdl.handle.net/1956/16984
dc.language.isoengeng
dc.publisherThe University of Bergeneng
dc.relation.haspartPaper I: Halle MK, Werner H, Krakstad, C, Birkeland E, Wik E, Trovik, J, Salvesen, HB: Stratification based on high tumour cell content in fresh frozen tissue promotes selection of aggressive endometrial carcinomas. Histopathology. 2012;60:516-9. The article is not available in BORA due to publisher restrictions. The published version is available at: <a href=" https://doi.org/10.1111/j.1365-2559.2011.04057.x" target="blank"> https://doi.org/10.1111/j.1365-2559.2011.04057.x</a>en_US
dc.relation.haspartPaper II: Halle MK, Krakstad C, Engerud H, Bertelsen B, Salvesen H: Molecular profiling in fresh tissue with high tumor cell content promotes enrichment for aggressive adenocarcinomas in cervix. Pathol Res Pract. 2014;210:774-8. The article is not available in BORA due to publisher restrictions. The published version is available at: <a href=" https://doi.org/10.1016/j.prp.2014.07.002" target="blank"> https://doi.org/10.1016/j.prp.2014.07.002</a>en_US
dc.relation.haspartPaper III: Halle MK, Ojesina AI, Engerud H, Woie K, Tangen IL, Holst F, Hoivik E, Kusonmano K, Haldorsen IS, Vintermyr OK, Trovik J, Bertelsen BI, Salvesen HB, Krakstad C: Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study. Am J Obstet Gynecol. 2017;217:432.e1-432.e17. The article is not available in BORA due to publisher restrictions. The published version is available at: <a href=" https://doi.org/10.1016/j.ajog.2017.05.068" target="blank"> https://doi.org/10.1016/j.ajog.2017.05.068</a>en_US
dc.relation.haspartPaper IV: Halle MK, Tangen IL, Berg HF, Hoivik EA, Mauland KK, Kusonmano K, Berg A, Hurtado A, Kalland KH, Øyan AM, Stefansson I, Vintermyr OK, Werner HMJ, Haldorsen IS, Trovik J, Salvesen HB, Krakstad C: HER2 expression patterns in paired primary and metastatic endometrial cancer lesions. Br J Cancer. 2018;118:378–387. <a href="http://hdl.handle.net/1956/16983" target="blank"> http://hdl.handle.net/1956/16983</a>en_US
dc.relation.haspartPaper V: Gilfillan S, Halle MK, Sign S, Tangen IL, Katika MR, Salvesen HB, Krakstad C, Hurtado A: FOXA1 predicts good outcome in HER2+ endometrial cancer patients by inhibiting EGFR/HER2 signaling. The article is not available in BORA.en_US
dc.titleMolecular alterations suggesting new treatment strategies in uterine carcinomasen_US
dc.typeDoctoral thesis
dc.rights.holderCopyright the author. All rights reserved
dc.identifier.cristin1511556
dc.subject.nsiVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel